SAB Biotherapeutics (SABS)

(99% Neutral) SAB BIOTHERAPEUTICS, INC. (SABS) Announces Enrollment Update for used Due to Pandemic-Related Challenges, Patient Enrollment Issues, Manufacturing Considerations, Efficacy Assessment

Seres Therapeutics Inc (MCRB)

(90% Positive) SERES THERAPEUTICS, INC. (MCRB) Announces Enrollment Update for capacity Due to Pandemic-Related Challenges, Patient Enrollment Issues, Manufacturing Considerations, Safety Review, Efficacy Assessment